Stop the war!

Остановите войну!

for scientists:

default search action

combined dblp search
author search
venue search
publication search

ask others

César de Pablo-Sánchez

Name: dblp XML data dump
Creator: Schloss Dagstuhl - Leibniz Center for Informatics
Published: 1993
License: https://creativecommons.org/publicdomain/zero/1.0/
Keywords: dblp, XML, computer science, scholarly publications, metadata

◀ ▶ joint publications with Mario Crespo

> Home > Persons > César de Pablo-Sánchez

Publications

2010
[j4]
- view
  - electronic edition via DOI (open access)
  - references & citations
  authority control:
- export record
  dblp key:
  - journals/bmcbi/Segura-BedmarCPM10
- ask others
- share record
  persistent URL:
  - https://dblp.org/rec/journals/bmcbi/Segura-BedmarCPM10
Isabel Segura-Bedmar, Mario Crespo, César de Pablo-Sánchez, Paloma Martínez:
Resolving anaphoras for the extraction of drug-drug interactions in pharmacological documents. BMC Bioinform. 11(S-2): 1 (2010)
2009
[c21]
- view
  authority control:
- export record
  dblp key:
  - conf/cikm/Segura-BedmarCPM09
- ask others
- share record
  persistent URL:
  - https://dblp.org/rec/conf/cikm/Segura-BedmarCPM09
Isabel Segura-Bedmar, Mario Crespo, César de Pablo-Sánchez, Paloma Martínez:
DrugNerAR: linguistic rule-based anaphora resolver for drug-drug interaction extraction in pharmacological documents. DTMBIO 2009: 19-26
[c16]
- view
  authority control:
- export record
  dblp key:
  - conf/nldb/Segura-BedmarCP09
- ask others
- share record
  persistent URL:
  - https://dblp.org/rec/conf/nldb/Segura-BedmarCP09
Isabel Segura-Bedmar, Mario Crespo, César de Pablo-Sánchez:
Score-Based Approach for Anaphora Resolution in Drug-Drug Interactions Documents. NLDB 2009: 91-102

a service of

manage site settings

To protect your privacy, all features that rely on external API calls from your browser are turned off by default. You need to opt-in for them to become active. All settings here will be stored as cookies with your web browser. For more information see our F.A.Q.